Categories: News

ZAGENO’s New Operations Leader Delivers Consumer Expertise from Apple

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Kostas Sereleas

Senior VP of Operations at ZAGENOSenior VP of Operations at ZAGENO
Senior VP of Operations at ZAGENO

CAMBRIDGE, Mass., Dec. 07, 2021 (GLOBE NEWSWIRE) — ZAGENO, a leading enterprise marketplace connecting eCommerce to Life Science, today announced the appointment of Konstantinos (Kostas) Sereleas to the role of Senior Vice President of Operations. Kostas, who expands ZAGENO’s San Francisco-based management team, brings business to consumer experience from leadership roles at Apple, McKesson Pharmaceutical, and Blue Cross Blue Shield.

“I’m very excited to join ZAGENO’s operations team and lead an effort to build a framework to transform the company’s vision into an exceptional experience for our customers,” said Kostas Sereleas, Senior VP of Operations at ZAGENO. “Beyond the goals of our operations team, it is my enthusiasm to support researchers through a company mission to ease the lab supply ordering process.”

“For the life science community we serve, Kostas delivers an impressive record of success in building sustainable, automated solutions from some of today’s most successful business brands,” said Florian Wegener, Co-Founder, and CEO of ZAGENO. “We’re especially excited that Kostas brings best practices in B2C consumer experiences, developed at Apple, to ZAGENO’s B2B pharma and biotech customers.”

ZAGENO and its people are the recipients of several industry accolades. The ProcureTech100 has identified ZAGENO as one of the 100 pioneering digital procurement solutions for 2021. EY has recognized ZAGENO’s CEO as a finalist for Entrepreneur of the Year 2021 and 2020. Team members have been acknowledged by Insights Care as One of the 10 Most Admirable Women Leaders in Biotech for 2021, as well as one of the Top 25 Women Leaders in Biotechnology of 2020 by The Healthcare Technology Report. In addition, the ZAGENO platform has received the 2020 and 2019 Life Science eCommerce Global Customer Value Leadership Awards from Frost and Sullivan.

ZAGENO supports researchers pursuing breakthroughs that improve our lives. Through a marketplace that includes tens of millions of specialty, commodity, and industry-leading products, ZAGENO is the single source of supplies for the researcher community. ZAGENO’s digital tools transform the process of product comparisons, availability, price, and purchase. Founded in 2015, ZAGENO is a global company with offices in the US, UK, Germany, Belgium, and India. Learn more at www.zageno.com.

CONTACT:

Greg Vitarelli
Global Head of Communications
PHONE NUMBER: 6174559627
Email: greg@zageno.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e2fcf91a-541a-4602-9ed2-54ff704419db

Staff

Recent Posts

TEN RESEARCHERS HONORED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

TORONTO, July 27, 2025 /PRNewswire/ -- The Alzheimer's Association® will present 10 scientific awards at…

14 hours ago

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

2 days ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

2 days ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

2 days ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

2 days ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

2 days ago